Data Characteristics for This Category
Solid tumor product data primarily comes from clinical trial reports, drug monographs, research papers, genomic data, and regulatory approval documents. Update frequencies vary; clinical trial data and research papers might update quarterly or annually, while drug monographs and approval documents update as needed during a product's lifecycle. Document structures are mostly unstructured text (e.g., PDFs, Word documents), containing tables, charts, and extensive medical terminology. Data fields include drug targets, mechanisms of action, indications, contraindications, adverse reactions, dosage and administration, clinical efficacy indicators (e.g., OS, PFS, ORR), and gene mutation information (e.g., BRAF V600E, PD-L1 expression). Units typically include dosage units (mg, µg), time units (weeks, months, years), and biological indicator units (ng/mL, copy number).
Constraints Imposed by These Characteristics on Tool Calling and Plugins
The diverse sources and unstructured nature of solid tumor data require robust data preprocessing capabilities from the tool calling module. Extensive medical terminology and abbreviations necessitate specialized dictionaries or ontologies to ensure tools accurately parse query intent and match relevant information. The complexity of clinical indicators and the variety of units demand strict validation during parameter passing and result parsing to prevent misinterpretations due to unit mismatches. Inconsistent data update frequencies mean the knowledge base needs incremental update and version management capabilities to ensure the timeliness of tool-called data. Furthermore, due to high-dimensional data like genomics, tools might need integration with external specialized databases (e.g., TCGA, COSMIC), requiring extensible and stable plugin interfaces.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
maxContext | 8000 tokens | Solid tumor product descriptions and clinical reports are often lengthy, requiring a larger context window to capture key information. |
Similarity Threshold | 0.75 | Ensures highly relevant document snippets are recalled amidst extensive medical terminology, reducing interference from irrelevant information. |
Reranked Top K | Top 5 | Improves the precision of recall results, reduces the model's processing burden, and focuses on core content. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Processing large PDF clinical trial reports requires a longer file parsing time. |
Chunk Length | 500 characters | Balances semantic completeness and fragment granularity, aiding model comprehension, especially for documents with complex tables. |
Tool Call Timeout | 120 seconds | Queries to external gene databases or complex data analyses can be time-consuming, requiring ample response time. |
Three Common Pitfalls
- Tool calling module does not trigger: The model answers directly or refuses to answer. This happens when the
tool descriptionis unclear or insufficiently related to the user's query intent, preventing the model from identifying when to use the tool. - Tool call returns empty results or errors: The model cannot provide specific data. This usually occurs due to insufficient validation of plugin input parameters, leading to unexpected parameter formats or data types being passed to external tools.
- Knowledge base conflicts with tool calling: The model prioritizes retrieving from the knowledge base even when a tool could be called. This happens when
recall countorsimilarity thresholdare misconfigured, causing the knowledge base to recall a large amount of seemingly relevant but imprecise information, which affects tool calling priority.
How to Confirm Proper Configuration
- Verify that tool calls accurately trigger in specific scenarios for various solid tumor product queries, such as querying
PD-L1 expressionrelated data for a drug. - Check tool call logs to confirm that input and output parameters for external plugins conform to expectations, particularly for queries involving
gene mutationsorclinical efficacy indicators. - Simulate various abnormal inputs to verify the robustness of the tool call's error handling mechanism, for example, inputting a non-existent drug name or an incorrect gene locus.
The values given are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.